Evidence map›Paper›PMID 33763649›Full record

ArticleFunction (Oxford, England)2021

PIP

Amreen Mughal, Osama F Harraz, Albert L Gonzales, David Hill-Eubanks, Mark T Nelson

Open access · goldAbstract read
In one paragraph

Article in Function (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Cerebral capillary computation.American journal of physiology. Cell physiology · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. PIPProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Amyloid β alters vascular CaThe Journal of physiology · 2025
    Article
  14. Systemic Piezo1 activation improves cerebrovascular function in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Article
  16. Review
  17. Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Amreen MughalDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-0046-2286
Osama F HarrazDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.ORCID 0000-0003-2061-1100
Albert L GonzalesDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
David Hill-EubanksDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Mark T NelsonDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
University of Vermont · US

Funding

Vermont Center for Cardiovascular and Brain HealthP20GM135007 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Diego Adrianzen Herrera · 2020 to 2026
$17.4M
Impact of SAH on Parenchymal Arterioles and Neurovascular CouplingP01HL095488 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BONEV, ADRIAN · 2010 to 2014
$11.4M
Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and DiseaseR35HL140027 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2025
$6.3M
TRP Channel-Dependent Regulation of Arterial Tone (Renewal)R01HL091905 · NHLBI · UNIVERSITY OF NEVADA RENO · PI EARLEY, SCOTT · 2009 to 2020
$5.1M
Center for Neuroscience ExcellenceP30GM103498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2012 to 2015
$4.3M
Capillary control of cerebral blood flow, and its disruption in small vessel diseaseR01HL136636 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Fabrice Dabertrand · 2017 to 2026
$3.8M
Ion Channel Dysfunction in Small Vessel Disease of the BrainR01NS110656 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2023
$2.6M
CA++ SPARKS &URINARY BLADDER SMOOTH MUSCLE EXCITABILITYR01DK053832 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI NELSON, MARK T · 1998 to 2006
$2.0M
Regulations of Myoendothelial Function By Signaling Microdomains in HypertensionR01HL121706 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2014 to 2017
$1.6M
K+ sensing & electrical signaling by Kir channels in brain vasculatureR01HL131181 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2016 to 2018
$1.4M
Pericyte Control of Junctional Blood FlowK01HL138215 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI GONZALES, ALBERT LOUIS · 2017 to 2021
$744k
Acquisition of a Zeiss LSM 7 MP multiphoton microscopeS10OD010583 · OD · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2012 to 2012
$599k
American Heart Association-American Stroke Association 17POST33650030American Heart Association-American Stroke Association 20CDA35310097 - OSAMA HARRAZNHLBI NIH HHS K01 HL138215NHLBI NIH HHS P01 HL095488NHLBI NIH HHS R01 HL091905NHLBI NIH HHS R01 HL121706NHLBI NIH HHS R01 HL131181NHLBI NIH HHS R35 HL140027NIDDK NIH HHS R01 DK053832NIGMS NIH HHS P20 GM135007NIGMS NIH HHS P30 GM103498NIH HHS S10 OD010583NINDS NIH HHS R01 NS110656
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a leading cause of dementia and a substantial healthcare burden. Despite this, few treatment options are available for controlling AD symptoms. Notably, neuronal activity-dependent increases in cortical cerebral blood flow (CBF; functional hyperemia) are attenuated in AD patients, but the associated pathological mechanisms are not fully understood at the molecular level. A fundamental mechanism underlying functional hyperemia is activation of capillary endothelial inward-rectifying K

Indexed as

Alzheimer DiseaseHyperemiaCerebrovascular CirculationEndothelial CellsHumansPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol 4,5-DiphosphateAlzheimer’s diseasecapillariescerebral blood flowendothelial cellsfunctional hyperemiaKir2.1neurovascular couplingphosphoinositidesPIP2potassium channels

Identifiers

PMID33763649
PMCPMC7955025
OpenAlexW3131331170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.